Many CHIP participants that are hypertensive at the start of the program
dramatically reduce and sometimes eliminate their need for medication.
19.8% reduction in average total cholesterol in 30 days for those with baseline cholesterol of higher than 280mg/dl (7.24 mmol/l).
19.9% reduction in average fasting plasma glucose in 30 days for those with baseline fasting plasma glucose of higher than 125mg/dl (6.94 mmol/l).
Participants report reduced BMI by the average of 3% within just 30 days and with long term adherence to the lifestyle resulting in achieving ideal body weight.
Комментариев нет:
Отправить комментарий